IGPA Letter Regarding TGA Guidance titled “Evaluation of Biosimilars”

In an era when increasing demands are being made on the world’s healthcare services, generic medicines provide a major benefit to society by ensuring patient access to quality, safe and effective medicines while reducing the cost of pharmaceutical care. The International Generic Pharmaceutical Alliance (IGPA) was born as an international network of generic medicines associations, committed to promoting generic medicines and exchanging information worldwide.


IGPA Statement on the Trans-Pacific Partnership (TPP) Negotiations

The Asia-Pacific Region is of key importance to the generic pharmaceutical industry. It is the location of hundreds of generic manufacturing facilities and strategic export opportunities.  It is also an important source of pharmaceutical ingredients and other raw material inputs for our high-quality, low-cost medicines. As such, IGPA strongly supports efforts to expand trade in the region through the Trans-Pacific Partnership (TPP) negotiations.


IGPA organizes its annual conference in Brussels in december, registrations are open

The 16th Annual Conference of the International Generic Pharmaceutical Alliance (IGPA) will be held on December 9-11 in Brussels - Belgium.

Contact Info


c/o Interexperts SA
Rue des Pierres-du-Niton 17
1207 Geneva, Switzerland

Telephone: +32 (0)2 5346607
This email address is being protected from spambots. You need JavaScript enabled to view it.  
This email address is being protected from spambots. You need JavaScript enabled to view it.

We use cookies to improve our website and your experience when using it. Cookies used for the essential operation of the site have already been set. To find out more about the cookies we use and how to delete them, see our Privacy Policy.

I accept cookies from this site